221 related articles for article (PubMed ID: 31963441)
1.
Nanda N; Roberts NJ
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31963441
[TBL] [Abstract][Full Text] [Related]
2. Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants.
Hutchings D; Jiang Z; Skaro M; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Zheng L; Klimstra DS; Brand RE; Singhi AD; Goggins M; Klein AP; Roberts NJ; Hruban RH
Mod Pathol; 2019 Dec; 32(12):1806-1813. PubMed ID: 31285527
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic
Hannan Z; Yu S; Domchek S; Mamtani R; Reiss KA
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733050
[TBL] [Abstract][Full Text] [Related]
4. Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.
Gout J; Perkhofer L; Morawe M; Arnold F; Ihle M; Biber S; Lange S; Roger E; Kraus JM; Stifter K; Hahn SA; Zamperone A; Engleitner T; Müller M; Walter K; Rodriguez-Aznar E; Sainz B; Hermann PC; Hessmann E; Müller S; Azoitei N; Lechel A; Liebau S; Wagner M; Simeone DM; Kestler HA; Seufferlein T; Wiesmüller L; Rad R; Frappart PO; Kleger A
Gut; 2021 Apr; 70(4):743-760. PubMed ID: 32873698
[TBL] [Abstract][Full Text] [Related]
5. ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications.
Armstrong SA; Schultz CW; Azimi-Sadjadi A; Brody JR; Pishvaian MJ
Mol Cancer Ther; 2019 Nov; 18(11):1899-1908. PubMed ID: 31676541
[TBL] [Abstract][Full Text] [Related]
6. OCIAD1 promoted pancreatic ductal adenocarcinoma migration by regulating ATM.
Ji W; Zheng K; Song B; Qin A; Chandoo A; Shao Z; Bi J; Yang X; Jin G; Shen X
Pancreatology; 2019 Jul; 19(5):751-759. PubMed ID: 31221523
[TBL] [Abstract][Full Text] [Related]
7. Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.
Abe T; Blackford AL; Tamura K; Ford M; McCormick P; Chuidian M; Almario JA; Borges M; Lennon AM; Shin EJ; Klein AP; Hruban RH; Canto MI; Goggins M
J Clin Oncol; 2019 May; 37(13):1070-1080. PubMed ID: 30883245
[TBL] [Abstract][Full Text] [Related]
8. EUS-based Pancreatic Cancer Surveillance in
Katona BW; Long JM; Ahmad NA; Attalla S; Bradbury AR; Carpenter EL; Clark DF; Constantino G; Das KK; Domchek SM; Dudzik C; Ebrahimzadeh J; Ginsberg GG; Heiman J; Kochman ML; Maxwell KN; McKenna DB; Powers J; Shah PD; Wangensteen KJ; Rustgi AK
Cancer Prev Res (Phila); 2021 Nov; 14(11):1033-1040. PubMed ID: 34341011
[TBL] [Abstract][Full Text] [Related]
9. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition.
Russell R; Perkhofer L; Liebau S; Lin Q; Lechel A; Feld FM; Hessmann E; Gaedcke J; Güthle M; Zenke M; Hartmann D; von Figura G; Weissinger SE; Rudolph KL; Möller P; Lennerz JK; Seufferlein T; Wagner M; Kleger A
Nat Commun; 2015 Jul; 6():7677. PubMed ID: 26220524
[TBL] [Abstract][Full Text] [Related]
10. Somatic loss of ATM is a late event in pancreatic tumorigenesis.
Paranal RM; Jiang Z; Hutchings D; Kryklyva V; Gauthier C; Fujikura K; Nanda N; Huang B; Skaro M; Wolfgang CL; He J; Klimstra DS; Brand RE; Singhi AD; DeMarzo A; Zheng L; Goggins M; Brosens LA; Hruban RH; Klein AP; Lotan T; Wood LD; Roberts NJ
J Pathol; 2023 Aug; 260(4):455-464. PubMed ID: 37345735
[TBL] [Abstract][Full Text] [Related]
11. Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
Ohmoto A; Morizane C; Kubo E; Takai E; Hosoi H; Sakamoto Y; Kondo S; Ueno H; Shimada K; Yachida S; Okusaka T
J Gastroenterol; 2018 Oct; 53(10):1159-1167. PubMed ID: 29667044
[TBL] [Abstract][Full Text] [Related]
12. A role for ATM in hereditary pancreatic cancer.
Bakker JL; de Winter JP
Cancer Discov; 2012 Jan; 2(1):14-5. PubMed ID: 22585162
[TBL] [Abstract][Full Text] [Related]
13. ATM- and ATR-induced primary ciliogenesis promotes cisplatin resistance in pancreatic ductal adenocarcinoma.
Chao YY; Huang BM; Peng IC; Lee PR; Lai YS; Chiu WT; Lin YS; Lin SC; Chang JH; Chen PS; Tsai SJ; Wang CY
J Cell Physiol; 2022 Dec; 237(12):4487-4503. PubMed ID: 36251015
[TBL] [Abstract][Full Text] [Related]
14. Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy.
Roger E; Gout J; Arnold F; Beutel AK; Müller M; Abaei A; Barth TFE; Rasche V; Seufferlein T; Perkhofer L; Kleger A
Cells; 2020 Sep; 9(9):. PubMed ID: 32948057
[TBL] [Abstract][Full Text] [Related]
15. ATM mutations in patients with hereditary pancreatic cancer.
Roberts NJ; Jiao Y; Yu J; Kopelovich L; Petersen GM; Bondy ML; Gallinger S; Schwartz AG; Syngal S; Cote ML; Axilbund J; Schulick R; Ali SZ; Eshleman JR; Velculescu VE; Goggins M; Vogelstein B; Papadopoulos N; Hruban RH; Kinzler KW; Klein AP
Cancer Discov; 2012 Jan; 2(1):41-6. PubMed ID: 22585167
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of ATM-deficient pancreatic cancer cells to radiation.
Ayars M; Eshleman J; Goggins M
Cell Cycle; 2017 May; 16(10):991-998. PubMed ID: 28453388
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Adenocarcinoma.
Ohmoto A; Yachida S; Kubo E; Takai E; Suzuki M; Shimada K; Okusaka T; Morizane C
Pancreas; 2016 Aug; 45(7):1056-61. PubMed ID: 26692440
[TBL] [Abstract][Full Text] [Related]
18. ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage.
Perkhofer L; Schmitt A; Romero Carrasco MC; Ihle M; Hampp S; Ruess DA; Hessmann E; Russell R; Lechel A; Azoitei N; Lin Q; Liebau S; Hohwieler M; Bohnenberger H; Lesina M; Algül H; Gieldon L; Schröck E; Gaedcke J; Wagner M; Wiesmüller L; Sipos B; Seufferlein T; Reinhardt HC; Frappart PO; Kleger A
Cancer Res; 2017 Oct; 77(20):5576-5590. PubMed ID: 28790064
[TBL] [Abstract][Full Text] [Related]
19. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.
Roberts NJ; Grant RC; Gallinger S; Klein AP;
Genes Chromosomes Cancer; 2021 Aug; 60(8):559-564. PubMed ID: 33724601
[TBL] [Abstract][Full Text] [Related]
20. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]